VIRIDIAN THERAPEUTICS INC shareholders Q3 2023

VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.

VIRIDIAN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Eversept Partners, LP 443,270$6,799,7620.58%
Perceptive Advisors 1,011,205$15,511,8850.52%
Artal Group S.A. 504,978$7,7460.33%
PFM Health Sciences, LP 360,830$5,535,1320.26%
SILVERARC CAPITAL MANAGEMENT, LLC 47,438$727,6990.22%
Polar Capital Holdings Plc 1,600,000$24,544,0000.18%
DCF Advisers, LLC 13,500$207,0900.11%
Weiss Multi-Strategy Advisers LLC 131,671$2,0200.05%
EAGLE ASSET MANAGEMENT INC 459,169$7,043,6520.04%
Knights of Columbus Asset Advisors LLC 29,553$453,3430.04%
PROFUND ADVISORS LLC 43,959$674,3310.04%
Jump Financial, LLC 61,654$945,7720.04%
UBS OCONNOR LLC 84,836$1,301,3840.03%
Virtus ETF Advisers LLC 3,572$54,7940.03%
MARSHALL WACE, LLP 962,493$14,764,6430.03%
TWINBEECH CAPITAL LP 94,005$1,442,0370.03%
Hennion & Walsh Asset Management, Inc. 27,112$415,8980.03%
Polar Asset Management Partners Inc. 76,600$1,175,0440.03%
ExodusPoint Capital Management, LP 174,621$2,6790.03%
Rafferty Asset Management, LLC 262,296$4,023,6210.02%
External links

This page lists VIRIDIAN THERAPEUTICS INC's shareholders in Q3 2023. To view VIRIDIAN THERAPEUTICS INC's shareholder history, click here.